This video segment discusses strategies to help CAR-T therapy patients maintain quality of life, focusing on lifestyle ...

Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that ...

The 2-year benefit of bevacizumab in colorectal cancer may explain why survival benefits are seen in studies with two-year, ...

Several new treatment options for patients with breast cancer have emerged over the last few years, including more oral ...

This video segment explores the challenges of managing neurologic toxicities, including ICANS, in CAR-T therapy, highlighting ...

Key opinion leaders examine approaches to managing skin-related side effects, such as rash, in patients on EGFR inhibitors, ...

BC, CNM, RNFA, spoke about the oncology nurse’s and APP’s roles in managing chemotherapy-induced peripheral neuropathy in ...

T-DXd has received FDA approval for the treatment of unresectable or metastatic HR+, HER2-low/-ultralow breast cancer in ...

Phone calls to follow up with patients with locally advanced esophageal squamous cell carcinoma while at home may reduce AEs ...

Managing weight loss with telotristat ethyl in patients with metastatic pancreatic ductal adenocarcinoma may improve survival ...

Findings from this survey also demonstrated that 23% of providers were comfortable with interpreting biomarker testing ...

Dr. Mohan discusses with Nurse Goff and Nurse Brigle the prevention and management of infections and neurological toxicities in patients receiving bispecific therapies, with a particular focus on the ...